Your browser doesn't support javascript.
loading
CACHE (Critical Assessment of Computational Hit-finding Experiments): A public-private partnership benchmarking initiative to enable the development of computational methods for hit-finding.
Ackloo, Suzanne; Al-Awar, Rima; Amaro, Rommie E; Arrowsmith, Cheryl H; Azevedo, Hatylas; Batey, Robert A; Bengio, Yoshua; Betz, Ulrich A K; Bologa, Cristian G; Chodera, John D; Cornell, Wendy D; Dunham, Ian; Ecker, Gerhard F; Edfeldt, Kristina; Edwards, Aled M; Gilson, Michael K; Gordijo, Claudia R; Hessler, Gerhard; Hillisch, Alexander; Hogner, Anders; Irwin, John J; Jansen, Johanna M; Kuhn, Daniel; Leach, Andrew R; Lee, Alpha A; Lessel, Uta; Morgan, Maxwell R; Moult, John; Muegge, Ingo; Oprea, Tudor I; Perry, Benjamin G; Riley, Patrick; Rousseaux, Sophie A L; Saikatendu, Kumar Singh; Santhakumar, Vijayaratnam; Schapira, Matthieu; Scholten, Cora; Todd, Matthew H; Vedadi, Masoud; Volkamer, Andrea; Willson, Timothy M.
Affiliation
  • Ackloo S; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Al-Awar R; Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Amaro RE; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
  • Arrowsmith CH; Department of Chemistry and Biochemistry, UC San Diego, La Jolla, CA, USA.
  • Azevedo H; Drug Design Data Resource, University of California, San Diego, La Jolla, CA, USA.
  • Batey RA; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Bengio Y; Aché Laboratórios Farmacêuticos, Guarulhos, São Paulo, Brazil.
  • Betz UAK; Department of Chemistry, University of Toronto, Toronto, Ontario, Canada.
  • Bologa CG; Mila, University of Montreal, Québec, Canada.
  • Chodera JD; Merck Healthcare KGaA, Darmstadt, Germany.
  • Cornell WD; Department of Internal Medicine, University of New Mexico School of Medicine, University of New Mexico Albuquerque, Albuquerque, NM, USA.
  • Dunham I; Computational and Systems Biology Program Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Ecker GF; Healthcare & Life Sciences Research, IBM TJ Watson Research Center, New York, USA.
  • Edfeldt K; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.
  • Edwards AM; Open Targets, Wellcome Genome Campus, Hinxton, UK.
  • Gilson MK; Department of Pharmaceutical Sciences, University of Vienna, Vienna, Austria.
  • Gordijo CR; Structural Genomics Consortium, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
  • Hessler G; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Hillisch A; Drug Design Data Resource, University of California, San Diego, La Jolla, CA, USA.
  • Hogner A; Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego, La Jolla, CA, USA.
  • Irwin JJ; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Jansen JM; Sanofi-Aventis Deutschland GmbH, R&D, Integrated Drug Discovery, Frankfurt am Main, Germany.
  • Kuhn D; Bayer AG, Pharmaceuticals, Research and Development, Wuppertal, Germany.
  • Leach AR; Medicinal Chemistry, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
  • Lee AA; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
  • Lessel U; Novartis Institutes for BioMedical Research, Emeryville, CA, USA.
  • Morgan MR; Merck Healthcare KGaA, Computational Chemistry & Biologics, Darmstadt, Germany.
  • Moult J; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, UK.
  • Muegge I; Open Targets, Wellcome Genome Campus, Hinxton, UK.
  • Oprea TI; PostEra Inc, San Franciso, CA, USA.
  • Perry BG; Department of Physics, University of Cambridge, Cambridge, UK.
  • Riley P; Boehringer Ingelheim Pharma GmbH & Co. KG, Medicinal Chemistry, Biberach an der Riss, Germany.
  • Rousseaux SAL; Structural Genomics Consortium, University of Toronto, Toronto, Ontario, Canada.
  • Saikatendu KS; Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.
  • Santhakumar V; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
  • Schapira M; Alkermes, Inc., Waltham, MA, USA.
  • Scholten C; Department of Internal Medicine, University of New Mexico School of Medicine, University of New Mexico Albuquerque, Albuquerque, NM, USA.
  • Todd MH; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.
  • Vedadi M; Drugs for Neglected Diseases initiative, Geneva, Switzerland.
  • Volkamer A; Relay Therapeutics, Boston, MA, USA.
  • Willson TM; Department of Chemistry, University of Toronto, Toronto, Ontario, Canada.
Nat Rev Chem ; 6(4): 287-295, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35783295
ABSTRACT
One aspirational goal of computational chemistry is to predict potent and drug-like binders for any protein, such that only those that bind are synthesized. In this Roadmap, we describe the launch of Critical Assessment of Computational Hit-finding Experiments (CACHE), a public benchmarking project to compare and improve small molecule hit-finding algorithms through cycles of prediction and experimental testing. Participants will predict small molecule binders for new and biologically relevant protein targets representing different prediction scenarios. Predicted compounds will be tested rigorously in an experimental hub, and all predicted binders as well as all experimental screening data, including the chemical structures of experimentally tested compounds, will be made publicly available, and not subject to any intellectual property restrictions. The ability of a range of computational approaches to find novel binders will be evaluated, compared, and openly published. CACHE will launch 3 new benchmarking exercises every year. The outcomes will be better prediction methods, new small molecule binders for target proteins of importance for fundamental biology or drug discovery, and a major technological step towards achieving the goal of Target 2035, a global initiative to identify pharmacological probes for all human proteins.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Nat Rev Chem Year: 2022 Document type: Article Affiliation country: Canada

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Diagnostic_studies / Prognostic_studies Language: En Journal: Nat Rev Chem Year: 2022 Document type: Article Affiliation country: Canada